ERBB2 and breast carcinoma: RBP7 expression was higher in PR-positive breast cancer patients than in PR-negative patients (Figure 6(b)), whereas RBP7 expression was higher in HER2-negative breast cancer patients than in HER2-positive patients (Figure 6(c)).